Publications in collaboration with researchers from Vall d'Hebron Institut de Recerca (12)

2022

  1. Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations

    Cells, Vol. 11, Núm. 13

2020

  1. Overexpression of corticotropin-releasing factor in intestinal mucosal eosinophils is associated with clinical severity in Diarrhea-Predominant Irritable Bowel Syndrome

    Scientific Reports, Vol. 10, Núm. 1

  2. Peripheral Corticotropin-Releasing Factor Triggers Jejunal Mast Cell Activation and Abdominal Pain in Patients With Diarrhea-Predominant Irritable Bowel Syndrome

    The American journal of gastroenterology, Vol. 115, Núm. 12, pp. 2047-2059

2019

  1. Mucosal RNA and protein expression as the next frontier in IBS: Abnormal function despite morphologically intact small intestinal mucosa

    American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 316, Núm. 6, pp. G701-G719

2018

  1. A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies

    Advances in Therapy, Vol. 35, Núm. 3, pp. 289-310

  2. Decreased TESK1-mediated cofilin 1 phosphorylation in the jejunum of IBS-D patients may explain increased female predisposition to epithelial dysfunction

    Scientific Reports, Vol. 8, Núm. 1

  3. Epithelial immunity: Priming defensive responses in the intestinal mucosa

    American Journal of Physiology - Gastrointestinal and Liver Physiology

2017

  1. Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: A pilot study

    United European Gastroenterology Journal, Vol. 5, Núm. 6, pp. 887-897

  2. MiR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea

    Gut, Vol. 66, Núm. 9, pp. 1597-1610

2016

  1. The joint power of sex and stress to modulate brain-gut-microbiota axis and intestinal barrier homeostasis: Implications for irritable bowel syndrome

    Neurogastroenterology and Motility, Vol. 28, Núm. 4, pp. 463-486

2015

  1. Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations

    Gut, Vol. 64, Núm. 9, pp. 1379-1388

  2. Role of corticotropin-releasing factor in gastrointestinal permeability

    Journal of Neurogastroenterology and Motility, Vol. 21, Núm. 1, pp. 33-50